Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (19)

« Back to Publications

It never rains but pours: disseminated nocardiosis in a renal transplant patient from Nigeria - a case report.

Whitehead T. et al, (2025), BMC Infect Dis, 26

Regulatory T cell therapy is associated with distinct immune regulatory lymphocytic infiltrates in kidney transplants.

McCallion O. et al, (2025), Med, 6

case of disseminated autochthonous Cladophialophora bantiana infection in a renal transplant recipient in the UK.

Mackrill SW. et al, (2025), Lancet Infect Dis, 25, e104 - e112

Late Treatment With Autologous Expanded Regulatory T-cell Therapy After Alemtuzumab Induction Is Safe and Facilitates Immunosuppression Minimization in Living Donor Renal Transplantation.

Brook MO. et al, (2024), Transplantation, 108, 2278 - 2286

GMP Protocol for the Manufacture of Tregs for Clinical Application.

O'Neil A. et al, (2023), 2559, 205 - 227

Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients.

Brook MO. et al, (2022), BMJ Open, 12

"Virtual ward" community outreach support for COVID-19-positive hemodialysis patients may delay but not prevent subsequent admission to hospital: A single-center retrospective case-control pilot study.

Gaied J. et al, (2022), Hemodial Int, 26, 278 - 280

Towards regulatory cellular therapies in solid organ transplantation.

Bottomley MJ. et al, (2022), Trends Immunol, 43, 8 - 21

Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients.

Harden PN. et al, (2021), Am J Transplant, 21, 1603 - 1611

New frontiers: cellular immunotherapy beyond cancer

Brook M. et al, (2019), Cell and Gene Therapy Insights, 5, 1229 - 1236

Communications: Designing care bundle documentation to support the recognition and treatment of acute kidney injury: A route to quality improvement

Black A. et al, (2017), 170 - 189

Repeat testing is essential when estimating chronic kidney disease prevalence and associated cardiovascular risk.

Brook MO. et al, (2012), QJM, 105, 247 - 255

Single estimated glomerular filtration rate and albuminuria measurement substantially overestimates prevalence of chronic kidney disease.

Bottomley MJ. et al, (2011), Nephron Clin Pract, 117, c348 - c352

Regulatory T cells can prevent memory CD8+ T-cell-mediated rejection following polymorphonuclear cell depletion.

Jones ND. et al, (2010), Eur J Immunol, 40, 3107 - 3116

Location and time-dependent control of rejection by regulatory T cells culminates in a failure to generate memory T cells.

Carvalho-Gaspar M. et al, (2008), J Immunol, 180, 6640 - 6648

Load More